Cambridge, MA, United States of America

Clemence Neurohr


Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2024-2025

Loading Chart...
2 patents (USPTO):

Title: Innovations in Pharmaceutical Processing: The Contributions of Inventor Clemence Neurohr

Introduction

Clemence Neurohr, an accomplished inventor based in Cambridge, MA, has made significant contributions to the field of pharmaceutical processing. With two patents to her name, Neurohr is recognized for her innovative approach to integrating critical processes involved in the handling of active pharmaceutical ingredients (APIs).

Latest Patents

Neurohr's latest patents focus on advanced technologies for the pharmaceutical industry. They are titled "Devices and methods for the integrated filtration, drying, and mechanical processing of active pharmaceutical ingredients," which encapsulates her work in developing efficient techniques for filtering, drying, and mechanically processing APIs. These innovations hold the potential to enhance the quality and production efficiency of pharmaceutical products.

Career Highlights

Clemence Neurohr's career is marked by her dedication to research and innovation within a renowned institution. She is affiliated with the Massachusetts Institute of Technology, where her work is at the intersection of engineering and pharmaceutical science. Her pioneering efforts have not only contributed to a better understanding of the manufacturing processes but also set new standards in the industry.

Collaborations

Throughout her professional journey, Neurohr has collaborated with notable colleagues, including David Brancazio and Allan Stuart Myerson. Such partnerships have enriched her research endeavors and expanded the scope of her inventions, leading to advancements that benefit the pharmaceutical sector.

Conclusion

Clemence Neurohr stands out as a leading inventor whose work continues to drive innovation in the pharmaceutical industry. Her patents reflect a commitment to improving the efficiency and effectiveness of drug manufacturing processes. As she continues her research at the Massachusetts Institute of Technology, her contributions are poised to impact the future of pharmaceutical sciences significantly.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…